Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.

[1]  Y. Atomi,et al.  Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria , 2007, Modern Pathology.

[2]  Y. Nakanuma,et al.  Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas , 2006, Hepatology.

[3]  Y. Jan,et al.  Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis. , 2006, Journal of hepatology.

[4]  R. Hruban,et al.  Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study , 2005, Virchows Archiv.

[5]  Y. Nimura,et al.  Frequent p16ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis. , 2004, Human pathology.

[6]  J. Kench,et al.  Pancreatic Intraepithelial Neoplasia in Association With Intraductal Papillary Mucinous Neoplasms of the Pancreas: Implications for Disease Progression and Recurrence , 2004, The American journal of surgical pathology.

[7]  S. Batra,et al.  Pathologic Features of Mucin-producing Bile Duct Tumors: Two Histopathologic Categories as Counterparts of Pancreatic Intraductal Papillary-mucinous Neoplasms , 2004, The American journal of surgical pathology.

[8]  E. Furth,et al.  Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. , 2003, Human pathology.

[9]  Motoko Sasaki,et al.  Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. , 2003, Journal of hepato-biliary-pancreatic surgery.

[10]  J. Kench,et al.  Aberrant p16INK4A and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma , 2002, Gut.

[11]  Y. Jan,et al.  Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. , 2002, Human pathology.

[12]  J. Kench,et al.  Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. , 2001, Cancer research.

[13]  Y. Jan,et al.  Intraductal papillary neoplasia of the liver associated with hepatolithiasis , 2001, Hepatology.

[14]  G. Zamboni,et al.  The Immunohistochemical Mucin Expression Pattern Distinguishes Different Types of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Determines Their Relationship to Mucinous Noncystic Carcinoma and Ductal Adenocarcinoma , 2001, The American journal of surgical pathology.

[15]  R. Hruban,et al.  Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts , 2001, Cancer.

[16]  Y. Nakanuma,et al.  Precancerous lesions of intrahepatic cholangiocarcinoma. , 2000, Journal of hepato-biliary-pancreatic surgery.

[17]  J. Cameron,et al.  Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. , 2000, The American journal of pathology.

[18]  R. Hruban,et al.  Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. , 2000, Cancer research.

[19]  W. Schmiegel,et al.  Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. , 1998, Cancer research.

[20]  Y. Nakanuma,et al.  Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply , 1997, Microscopy research and technique.

[21]  C. Moskaluk,et al.  Genomic Sequencing of DPC4 in the Analysis of Familial Pancreatic Carcinoma , 1997, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[22]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[23]  J. Massagué,et al.  Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.

[24]  Kathleen R. Cho,et al.  DPC4 gene in various tumor types. , 1996, Cancer research.

[25]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[26]  G. Hannon,et al.  The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.

[27]  J. Pines.  p21 inhibits cyclin shock , 1994, Nature.

[28]  Yi-Song Wang,et al.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. , 1994, Cancer research.

[29]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[30]  Steven K. Hanks,et al.  Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins , 1992, Cell.

[31]  A. Pardee.  G1 events and regulation of cell proliferation. , 1989, Science.

[32]  Y. Nakanuma,et al.  Biliary papillary neoplasm of the liver. , 2002, Histology and histopathology.

[33]  Cdm Fletcher,et al.  World Health Organization Classification of Tumours , 2002 .

[34]  A. Sparks,et al.  Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation , 2000 .

[35]  D. Longnecker.  Intraductal papillary-mucinous neoplasms of the pancreas , 2000 .